DK580282A - Fremgangsmaade til fremstilling af n-oxid-forbindelser eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af n-oxid-forbindelser eller salte deraf Download PDF

Info

Publication number
DK580282A
DK580282A DK580282A DK580282A DK580282A DK 580282 A DK580282 A DK 580282A DK 580282 A DK580282 A DK 580282A DK 580282 A DK580282 A DK 580282A DK 580282 A DK580282 A DK 580282A
Authority
DK
Denmark
Prior art keywords
lower alkyl
compounds
salts
radical
substituted
Prior art date
Application number
DK580282A
Other languages
English (en)
Inventor
Markus Zimmermann
Hans Kuehnis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK580282A publication Critical patent/DK580282A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Oxygen, Ozone, And Oxides In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
DK580282A 1981-12-30 1982-12-30 Fremgangsmaade til fremstilling af n-oxid-forbindelser eller salte deraf DK580282A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH835981 1981-12-30
CH225582 1982-04-14

Publications (1)

Publication Number Publication Date
DK580282A true DK580282A (da) 1983-07-01

Family

ID=25689928

Family Applications (1)

Application Number Title Priority Date Filing Date
DK580282A DK580282A (da) 1981-12-30 1982-12-30 Fremgangsmaade til fremstilling af n-oxid-forbindelser eller salte deraf

Country Status (18)

Country Link
US (1) US4497808A (da)
EP (1) EP0083315B1 (da)
AT (1) ATE28643T1 (da)
AU (1) AU556201B2 (da)
CA (1) CA1215053A (da)
DD (1) DD209456A5 (da)
DE (1) DE3276862D1 (da)
DK (1) DK580282A (da)
ES (4) ES518711A0 (da)
FI (1) FI824531A7 (da)
GB (1) GB2112782B (da)
GR (1) GR77073B (da)
HU (1) HU192760B (da)
IE (1) IE54496B1 (da)
IL (1) IL67602A0 (da)
NO (1) NO824420L (da)
NZ (1) NZ202959A (da)
PT (1) PT76057B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0111453A1 (de) * 1982-12-10 1984-06-20 Ciba-Geigy Ag Amid-Verbindungen
EP0125803A3 (en) * 1983-04-27 1987-01-21 FISONS plc Pharmaceutically active dihydropyridines
DE3410645A1 (de) * 1984-03-23 1985-09-26 Bayer Ag, 5090 Leverkusen L-alkylsubstituierte 1,4-dihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPH0676405B2 (ja) * 1986-06-13 1994-09-28 日清製粉株式会社 １，４―ジヒドロピリジン誘導体およびそれを含有する医薬組成物
US4833150A (en) * 1985-03-14 1989-05-23 Nelson Research & Development Co. 1,4-dihydropyridines
IT1215298B (it) * 1985-08-06 1990-01-31 Boehringer Biochemia Srl 2-(eteroalchil)-1,4-diidropiridine ed un processo per la loro produzione.
DE3601397A1 (de) * 1986-01-18 1987-07-23 Bayer Ag Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4849436A (en) * 1986-03-11 1989-07-18 Nelson Research & Development Co. 1,4-dihydropyridines
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
US5158963A (en) * 1989-08-02 1992-10-27 Kaken Pharmaceutical Co., Ltd. 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
USD1044219S1 (en) * 2021-06-04 2024-10-01 Crocs, Inc. Footwear

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545873A1 (de) * 1965-11-10 1970-02-26 Bayer Ag Verfahren zur Herstellung von Dihydrodipyridylderivaten
DE1792765A1 (de) * 1965-11-10 1974-10-10 Bayer Ag Verwendung von dihydrodipyridylen als kreislaufbeeinflussende mittel
US3862161A (en) * 1970-01-24 1975-01-21 Bayer Ag 4-pyridyl substituted 1,4-dihydropyridines
DE2003146A1 (de) * 1970-01-24 1971-07-29 Bayer Ag Neue 1,4-Dihydropyridinderivate
US3966948A (en) * 1970-01-24 1976-06-29 Bayer Aktiengesellschaft Spasmolytic, vaso-dilating and anti-hypertensive compositions and methods
US3920823A (en) * 1972-03-06 1975-11-18 Bayer Ag Use of unsymmetrical esters of n-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid as cardio-vascular agents
US3933834A (en) * 1972-03-06 1976-01-20 Bayer Aktiengesellschaft Unsymmetrical esters of N-substituted 1,4-dihydropyridine 3,5-dicarboxylic acid
DE2210672C3 (de) * 1972-03-06 1980-03-20 Bayer Ag, 5090 Leverkusen N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2228377A1 (de) * 1972-06-10 1974-01-03 Bayer Ag Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US3946027A (en) * 1972-09-30 1976-03-23 Bayer Aktiengesellschaft 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2616991A1 (de) * 1976-04-17 1977-10-27 Bayer Ag Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES530655A0 (es) 1985-12-01
GR77073B (da) 1984-09-05
ES8602666A1 (es) 1985-12-01
PT76057B (en) 1986-02-04
AU556201B2 (en) 1986-10-23
ES8405783A1 (es) 1984-06-16
DE3276862D1 (en) 1987-09-03
FI824531A0 (fi) 1982-12-30
GB2112782B (en) 1985-05-01
CA1215053A (en) 1986-12-09
EP0083315B1 (de) 1987-07-29
AU9195982A (en) 1983-07-07
ES8603456A1 (es) 1985-12-16
ATE28643T1 (de) 1987-08-15
EP0083315A2 (de) 1983-07-06
ES518711A0 (es) 1984-06-16
PT76057A (en) 1983-01-01
FI824531L (fi) 1983-07-01
ES530654A0 (es) 1986-11-16
ES530653A0 (es) 1985-12-16
IL67602A0 (en) 1983-05-15
FI824531A7 (fi) 1983-07-01
US4497808A (en) 1985-02-05
EP0083315A3 (en) 1983-08-24
IE54496B1 (en) 1989-10-25
ES8701160A1 (es) 1986-11-16
NO824420L (no) 1983-07-01
IE823092L (en) 1983-06-30
HU192760B (en) 1987-07-28
NZ202959A (en) 1985-11-08
GB2112782A (en) 1983-07-27
DD209456A5 (de) 1984-05-09

Similar Documents

Publication Publication Date Title
AU556201B2 (en) Oxido-pyridyl dihydropyridines
DE3264985D1 (en) 1,2,6-thiadiazine-3,5-dione-1,1 dioxides and their use
AR003414A1 (es) Uso de derivados de imidazol [1,2-a]piridina -3-acetamida y una composicion farmaceutica que comprende tal derivado
EP0143746A3 (de) Substituierte 5-Amino-4-hydroxyvalerylderivate
ATE21894T1 (de) Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln.
DE69503647D1 (de) Aminoheterocyclische derivate als antithrombotische oder antikoagulierende mittel
ES479931A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina.
NL7603947A (nl) Werkwijze voor de bereiding van fenylalkaancar- bonzuurderivaten.
CO5570660A2 (es) Indazolilpirrolotriazinas c-6 modificadas
ATE159514T1 (de) Substituierte aminsäure derivate verwendbar für die behandlung von arteriosclerosis
DE59010435D1 (de) Indolocarbazol-Derivate, Verfahren zu deren Herstellung und deren Verwendung
ATE28641T1 (de) Pharmazeutische praeparate, (+)-cyanidan-3-olderivate enthaltend, deren verwendung, substituierte (+)-cyanidan-3-ol derivate und verfahren zu deren herstellung.
DE3572816D1 (de) Pyridazinone inotropic agents
ATE36854T1 (de) Tetrahydrothienopyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
ATE67761T1 (de) N-acyl-dihydroresorufin-derivate, verfahren zu deren herstellung sowie deren verwendung zur bestimmung von wasserstoffperoxid, peroxidatisch wirkenden verbindungen oder peroxidase.
FI872980A0 (fi) Isokinolinfoereningar, vilka har en kvaevesubstituent i 4-positionen och vilka har kardiotona fosfodiesterasfraktion iii-inhiberade egenskaper och/eller njurvasodilatoriska egenskaper.
ATE20063T1 (de) 3-pyridyl-5-alkoxy(oder phenoxy- oder aralkyloxy- )pyrazol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE6648T1 (de) 4h-benzo(4,5)cyclohepta(1,2-b)furanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.
ATE19634T1 (de) Phosphonsaeureester.
ATE12240T1 (de) Neue oxime von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
JO1413B1 (en) Nitrogen derivatives of oxo compounds
NO932959L (no) Antiprolifererende og antiinflammatoriske forbindelser: 5- eller 6-deoksyheksose-monosakkarider som har en mettet nitrogenholdig heterocyklus ved 5- eller 6-stillingen, bundet ved nitrogenatomet

Legal Events

Date Code Title Description
ATS Application withdrawn
AHB Application shelved due to non-payment